PRIVILEGED & CONFIDENTIAL

Date: 27 April 2022

Acacia Pharma Group PLC (the "Company")

Information to be provided in connection with the General Meeting to be held on 19 May 2022.

The Company has today published a Scheme Document which contains the Notice of Meeting for the General Meeting to be held on 19 May 2022. The additional matters to be published on the Company's website, pursuant to section 311A of the Companies Act 2006, are set out below:

  • As at 25 April 2022, the Company's issued share capital consisted of 100,923,133 ordinary shares of £0.02 each (and no shares held in treasury). Each share carries one vote. Therefore, the total voting rights in respect of these shares is 100,923,133.

  • No members' statements, members' resolutions or members' matters of business have been received by the Company.

For further details please contact:

Anne-Marie ElsleyIR@acaciapharma.com

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Acacia Pharma Group plc published this content on 27 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 April 2022 10:34:27 UTC.